Basal ganglia cholinergic and dopaminerg
โ
Naomi M. Warren; Margaret A. Piggott; Elizabeth Greally; Michelle Lake; Andrew J
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 92 KB
## Abstract Progressive Supranuclear Palsy (PSP) is a progressive neurodegenerative disorder. In contrast to Parkinson's disease (PD) and dementia with Lewy bodies (DLB), replacement therapy with dopaminergic and cholinergic agents in PSP has been disappointing. The neurochemical basis for this is